Go back to Resource Center
Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341.
2000 Nov
Journal Article
Authors:
Wright, J.;
Hillsamer, V.L.;
Gore-Langton, R.E.;
Cheson, B.D.
Secondary:
Oncology (Williston Park)
Volume:
14
Pagination:
1589-90, 1593-4, 1597
Issue:
11
PMID:
11125942
Keywords:
Animals; Antineoplastic Agents; Boronic Acids; Bortezomib; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Hematologic Neoplasms; Humans; Neoplasms; Protease Inhibitors; Pyrazines
